Why the study?
Following an interim recommendation for nOPV2 use under emergency use listing, Nigeria sought to meet readiness criteria to roll out the vaccine for response efforts to ongoing cVDPV2 outbreaks.
Nigeria successfully met readiness criteria and initiated the rollout of the novel oral polio vaccine type 2 under emergency use listing to combat cVDPV2 outbreaks.
No takes yet. Share an insight, caveat, or question.
Operational lessons from Nigeria may guide nOPV2 planning; leaves open generalizability pending prospective validation.
Asekun et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: